1. Home
  2. APLE vs DYN Comparison

APLE vs DYN Comparison

Compare APLE & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apple Hospitality REIT Inc.

APLE

Apple Hospitality REIT Inc.

HOLD

Current Price

$13.40

Market Cap

2.9B

Sector

Real Estate

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$17.44

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APLE
DYN
Founded
2007
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.0B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
APLE
DYN
Price
$13.40
$17.44
Analyst Decision
Buy
Strong Buy
Analyst Count
8
14
Target Price
$13.00
$37.00
AVG Volume (30 Days)
3.9M
1.7M
Earning Date
05-04-2026
05-04-2026
Dividend Yield
7.12%
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$1,238,622,000.00
N/A
Revenue This Year
$2.31
N/A
Revenue Next Year
$2.35
N/A
P/E Ratio
$18.22
N/A
Revenue Growth
18.98
N/A
52 Week Low
$10.85
$8.25
52 Week High
$13.57
$25.00

Technical Indicators

Market Signals
Indicator
APLE
DYN
Relative Strength Index (RSI) 74.69 41.97
Support Level $11.43 $16.47
Resistance Level N/A $19.65
Average True Range (ATR) 0.25 0.98
MACD 0.06 -0.30
Stochastic Oscillator 83.27 5.45

Price Performance

Historical Comparison
APLE
DYN

About APLE Apple Hospitality REIT Inc.

Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: